Maniadakis相关文献与解析，生知库 | 链接生命科学的每一步

Kapritsou, Maria; Papanikolaou, Vasiliki; Maniadakis, Nikolaos; Garani-Papadatos, Tina; Kaitelidou, Daphne; Mantzanas, Michalis; Sergentanis, Theodoros N

发表日期：2026

文献求助收藏

Assessment of Psychological Distress in Surgical Patients: A Comparison Between Day Care and Long-Term Hospitalization in an Oncology Hospital

外科患者心理困扰评估：肿瘤医院日间护理与长期住院的比较

期刊:Healthcare

影响因子:2.7

doi:10.3390/healthcare14050626

Kapritsou, Maria; Sergentanis, Theodoros N; Maniadakis, Nikolaos; Papanikolaou, Vasiliki

Cost-effectiveness of semaglutide 2.4 mg versus liraglutide 3 mg for the treatment of obesity in Greece

在希腊，索玛鲁肽 2.4 毫克与利拉鲁肽 3 毫克治疗肥胖症的成本效益比较

期刊:Frontiers in Public Health

影响因子:3.4

doi:10.3389/fpubh.2025.1690211

Papantoniou, Panagiotis; Maniadakis, Nikolaos

Performance of Greek Public Hospitals Before and After the Economic Recession and the Pandemic: Application of a Novel Cost Malmquist Index for Comparing Productivity Across Multiple Groups

希腊公立医院在经济衰退和疫情前后的绩效：应用新型成本马尔姆奎斯特指数比较多个群体间的生产力

期刊:Healthcare

影响因子:2.7

doi:10.3390/healthcare13111253

Fourlopoulou, Argyro; Xenos, Panos; Messinios, George; Maniadakis, Nikolaos

发表日期：2025

文献求助收藏

A Short-Term Cost-Effectiveness Analysis of Tirzepatide Versus Semaglutide for the Treatment of Obesity in Greece

希腊肥胖症治疗中替拉帕肽与索马鲁肽的短期成本效益分析

期刊:Healthcare

影响因子:2.7

doi:10.3390/healthcare13162011

Papantoniou, Panagiotis; Maniadakis, Nikolaos

Semaglutide 2.4 mg versus Liraglutide 3 mg for the Treatment of Obesity in Greece: A Short-Term Cost-Effectiveness Analysis

在希腊，使用司美格鲁肽 2.4 mg 与利拉鲁肽 3 mg 治疗肥胖症的短期成本效益分析

期刊:Pharmacoeconomics-Open

影响因子:2.1

doi:10.1007/s41669-025-00561-7

Papantoniou, Panagiotis; Maniadakis, Nikolaos

Attributable Mortality for Pediatric and Neonatal Central Line-Associated Bloodstream Infections in Greece

希腊儿童和新生儿中心静脉导管相关血流感染的归因死亡率

期刊:Journal of Pediatric Intensive Care

影响因子:0.3

doi:10.1055/s-0041-1740448

Karagiannidou, Sofia; Kourlaba, Georgia; Zaoutis, Theoklis; Maniadakis, Nikolaos; Papaevangelou, Vassiliki

Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings

构建高附加值药物核心评价框架：方法论和研究结果报告1

期刊:

影响因子:

doi:10.1186/s12962-021-00311-6

Petykó, Zsuzsanna Ida; Kaló, Zoltán; Espin, Jaime; Podrazilová, Kateřina; Tesař, Tomáš; Maniadakis, Nikos; Fricke, Frank-Ulrich; Inotai, András

发表日期：2021

文献求助收藏

Time-Aware Multi-Agent Symbiosis

时间感知多智能体共生

期刊:Frontiers in Robotics and AI

影响因子:3

doi:10.3389/frobt.2020.503452

Maniadakis, Michail; Hourdakis, Emmanouil; Sigalas, Markos; Piperakis, Stylianos; Koskinopoulou, Maria; Trahanias, Panos

发表日期：2020

文献求助收藏

An Evaluation of Diagnosis-Related Group (DRG) Implementation Focused on Cancer DRGs in Greek Public Hospitals

希腊公立医院癌症相关诊断分组（DRG）实施情况评估

期刊:Pharmacoeconomics-Open

影响因子:2.1

doi:10.1007/s41669-019-0146-z

Panagiotopoulos, Panos; Maniadakis, Nikos; Papatheodoridis, George; Pektasidis, Dimitris

Machiavellianism in Healthcare: A Literature Review

医疗保健领域的马基雅维利主义：文献综述

Assessment of Psychological Distress in Surgical Patients: A Comparison Between Day Care and Long-Term Hospitalization in an Oncology Hospital

外科患者心理困扰评估：肿瘤医院日间护理与长期住院的比较

Cost-effectiveness of semaglutide 2.4 mg versus liraglutide 3 mg for the treatment of obesity in Greece

在希腊，索玛鲁肽 2.4 毫克与利拉鲁肽 3 毫克治疗肥胖症的成本效益比较

Performance of Greek Public Hospitals Before and After the Economic Recession and the Pandemic: Application of a Novel Cost Malmquist Index for Comparing Productivity Across Multiple Groups

希腊公立医院在经济衰退和疫情前后的绩效：应用新型成本马尔姆奎斯特指数比较多个群体间的生产力

A Short-Term Cost-Effectiveness Analysis of Tirzepatide Versus Semaglutide for the Treatment of Obesity in Greece

希腊肥胖症治疗中替拉帕肽与索马鲁肽的短期成本效益分析

Semaglutide 2.4 mg versus Liraglutide 3 mg for the Treatment of Obesity in Greece: A Short-Term Cost-Effectiveness Analysis

在希腊，使用司美格鲁肽 2.4 mg 与利拉鲁肽 3 mg 治疗肥胖症的短期成本效益分析

Attributable Mortality for Pediatric and Neonatal Central Line-Associated Bloodstream Infections in Greece

希腊儿童和新生儿中心静脉导管相关血流感染的归因死亡率

Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings

构建高附加值药物核心评价框架：方法论和研究结果报告1

Time-Aware Multi-Agent Symbiosis

时间感知多智能体共生

An Evaluation of Diagnosis-Related Group (DRG) Implementation Focused on Cancer DRGs in Greek Public Hospitals

希腊公立医院癌症相关诊断分组（DRG）实施情况评估